Added to YB: 2023-09-14
Pitch date: 2023-09-14
RXRX [bullish]
Recursion Pharmaceuticals, Inc.
-51.73%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.
Market Cap
$2.2B
Pitch Price
$8.66
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.52
P/E
-2.32
EV/Sales
36.18
Sector
Biotechnology
Category
N/A
Show full summary:
Recursion Pharmaceuticals, Inc. Class A RXRX
A summary for this pitch has not been created yet.
Read full article (0 min)